Vitamin D deficiency in HIV-infected South Africans: Common, and not associated with susceptibility, immune response, or outcome in HIV-associated cryptococcal meningitis

Vitamin D deficiency in HIV-infected South Africans: Common, and not associated with susceptibility, immune response, or outcome in HIV-associated cryptococcal meningitis

Bibliographic Details
Main Authors:	J.N. Jarvis, T. Bicanic, A. Loyse, G. Meintjes, L. Hogan, C.H. Roberts, S. Shoham, J.R. Perfect, N. Govender, T.S. Harrison
Format:	Article
Language:	English
Published:	Elsevier 2014-04-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971214010698

Similar Items

Starting ART following cryptococcal meningitis:The optimal time has yet to be defined
by: T A Bicanic, et al.
Published: (2013-09-01)

Combination Therapy for HIV-Associated Cryptococcal Meningitis—A Success Story
by: William J. Hurt, et al.
Published: (2021-12-01)

Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.
by: Bicanic, T, et al.
Published: (2009)

Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
by: Jarvis, J, et al.
Published: (2014)

Sertraline for HIV-associated cryptococcal meningitis.
by: Veringa, A, et al.
Published: (2016)

Adjunctive dexamethasone in HIV-associated cryptococcal meningitis
by: Beardsley, J, et al.
Published: (2016)

Cryptococcal meningitis: a neglected NTD?
by: Molloy, S, et al.
Published: (2017)

Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana
by: Nametso Kelentse, et al.
Published: (2022-06-01)

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
by: Brouwer, A, et al.
Published: (2004)

Thalidomide for Recurrence of Symptoms following HIV-Associated Cryptococcal Meningitis
by: Tangkai Qi, et al.
Published: (2023-06-01)

Combination Versus Monotherapy for the Treatment of HIV Associated Cryptococcal Meningitis
by: Shashank Anant Vaidhya, et al.
Published: (2015-02-01)

Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.
by: Bicanic, T, et al.
Published: (2009)

Pathways to care with HIV-associated cryptococcal meningitis in Botswana and Uganda: Findings from a qualitative methods study
by: David S. Lawrence, et al.
Published: (2023-12-01)

Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis
by: Jia Liu, et al.
Published: (2018-05-01)

Relationship of susceptibility testing of Cryptococcus neoformans to survival and mycological clearance in HIV associated cryptococcal meningitis
by: Day, J, et al.
Published: (2014)

Do intracerebral cytokine responses explain the harmful effects of dexamethasone in HIV-associated cryptococcal meningitis?
by: Beardsley, J, et al.
Published: (2018)

Cerebrospinal fluid HIV-1 viral load during treatment of cryptococcal Meningitis.
by: Brouwer, A, et al.
Published: (2010)

Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis
by: Kitonsa, J, et al.
Published: (2021)

Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis
by: Caleb P. Skipper, et al.
Published: (2022-09-01)

HIV-1C <i>env</i> and <i>gag</i> Variation in the Cerebrospinal Fluid and Plasma of Patients with HIV-Associated Cryptococcal Meningitis in Botswana
by: Nametso Kelentse, et al.
Published: (2020-12-01)

Cryptococcal Meningitis: Differences between Patients with and without HIV-Infection
by: Chutithep Teekaput, et al.
Published: (2023-03-01)

Cryptococcal meningitis
by: Day, J
Published: (2004)

The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda.
by: David S Lawrence, et al.
Published: (2022-10-01)

COVID-19, HIV, and Cryptococcal Meningitis Coinfections with Abnormal Laboratory Findings
by: Mina Aghamali, et al.
Published: (2023-01-01)

In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis.
by: Larsen, R, et al.
Published: (2007)

Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis.
by: Jonathan Kitonsa, et al.
Published: (2021-03-01)

MRSA bacteraemia complicating amphotericin B treatment of cryptococcal meningitis
by: J Scriven, et al.
Published: (2013-09-01)

Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV
by: Brendan O’Kelly, et al.
Published: (2021-05-01)

Prevalence of Cryptococcus gattii in Ugandan HIV-infected patients presenting with cryptococcal meningitis.
by: Abel Wembabazi, et al.
Published: (2022-01-01)

Divergent neuroimmune signatures in the cerebrospinal fluid predict differential gender-specific survival among patients with HIV-associated cryptococcal meningitis
by: Samuel Okurut, et al.
Published: (2023-12-01)

Analysis of the relationship between drug susceptibility of Cryptococcus neoformans isolates and mortality in HIV-negative cryptococcal meningitis
by: Zhihui Su, et al.
Published: (2024-03-01)

Prevalence, risk factors and outcome associated with cryptococcal meningitis in HIV positive patients in Algeria: case series and review of literature
by: A. Ouyahia, et al.
Published: (2023-03-01)

88462 Fluconazole distribution in CNS and gynecological tissues in HIV-related cryptococcal meningitis decedents
by: Melanie R. Nicol, et al.
Published: (2021-03-01)

Treatment of indolent, nonencapsulated cryptococcal meningitis associated with hydrocephalus
by: Sarah T. Garber, et al.
Published: (2012-01-01)

Combination antifungal therapy for cryptococcal meningitis.
by: Day, J, et al.
Published: (2013)

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries
by: Loyse, A, et al.
Published: (2018)

Cryptococcal Meningitis in HIV-Negative Patients: A 12-Year Single-Center Experience in China
by: Yu Huang, et al.
Published: (2023-01-01)

Cryptococcal meningitis among perinatally HIV‐infected adolescents: Case series on presentation and management challenges
by: Peter Puplampu, et al.
Published: (2023-02-01)

Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis.
by: Brouwer, A, et al.
Published: (2007)

Antifungal susceptibility does not correlate with fungal clearance or survival in AIDS associated cryptococcal meningitis
by: O'Connor, L, et al.
Published: (2020)